Monday's Small-Cap Winners & Losers

Small-cap stocks traded mostly under the shifty broad market Monday as names like Finish Line (FINL Quote) pulled things down significantly.

Indianapolis-based Finish Line will buy out fellow footwear retailer Genesco (GCO Quote) for an essentially huge premium of $54.50 a share. The all-cash transaction is valued at $1.5 billion.

Finish Line shares lost 8.7% at $11.53, while Genesco joined today's small-cap winners with a gain of 8.4%, or $4.15, to $53.75.

Encysive Pharmaceuticals (ENCY Quote) shares plummeted more than 43% on word of a third approvable letter from the Food and Drug Administration regarding Thelin, its proposed treatment for pulmonary arterial hypertension, due to a stated lack of evidence for the compound's effectiveness. That spelled out for Encysive a decisive loss against one of its rivals, and may lead to "significant reductions in its infrastructure and workforce in the U.S.," said the company.

Shares of Encysive, which is a component of the Russell 2000, closed at $2.32. The index gave back 0.2% to 846.28 as another member, Trump Entertainment Resorts (TRMP Quote), dropped on word Chief Executive James Perry will resign effective July 1. He will be replaced, in the interim, by chief operating officer Mark Juliano. Shares traded down 8.2% to $14.61.

New York-based electric utility U.S. Energy Systems (USEY Quote) was also deeply in negative territory after announcing that auditors issued a going-concern warning in its year-end results, which were filed earlier this month, citing "a working capital deficiency and ... continuing operating losses." Shares lost 25.2% to $3.11.